Showing results (11-20 of 44) with videos related to
Sort By:
Pageof 5
Frontiers in Pharmacology|September 14, 2012
The MET Oncogene as a Therapeutical Target in Cancer Invasive GrowthPaolo Luraghi, Florian Schelter, Achim Krüger, et al.STAR Protocols|November 16, 2023
Protocol for in vitro establishment of heterogeneous stem-like cultures derived from whole human glioblastoma tumorsFrancesca De Bacco, Francesca Orzan, Elena Casanova, et al.The EMBO Journal|January 8, 2025
The integrated stress response drives MET oncogene overexpression in cancersMarina Cerqua, Marco Foiani, Carla Boccaccio, et al.International Journal of Molecular Sciences|July 30, 2020
The Long-Lasting Protective Effect of HGF in Cardiomyoblasts Exposed to Doxorubicin Requires a Positive Feed-Forward Loop Mediated by Erk1,2-Timp1-Stat3Simona Gallo, Martina Spilinga, Elena Casanova, et al.Frontiers in Oncology|February 4, 2020
"Metastatic Cancer of Unknown Primary" or "Primary Metastatic Cancer"?Stefan Kolling, Ferdinando Ventre, Elena Geuna, et al.International Journal of Cancer|November 22, 2007
Fibroblast nemosis arrests growth and induces differentiation of human leukemia cellsEsko Kankuri, Olga Babusikova, Kristina Hlubinova, et al.The Journal of Biological Chemistry|June 18, 2010
A disintegrin and metalloproteinase-10 (ADAM-10) mediates DN30 antibody-induced shedding of the met surface receptorFlorian Schelter, Julia Kobuch, Marcia L Moss, et al.Clinical & Experimental Metastasis|July 27, 2011
Tumor cell-derived Timp-1 is necessary for maintaining metastasis-promoting Met-signaling via inhibition of Adam-10Florian Schelter, Martina Grandl, Bastian Seubert, et al.Nature|March 18, 2005
The MET oncogene drives a genetic programme linking cancer to haemostasisCarla Boccaccio, Gabriella Sabatino, Enzo Medico, et al.Journal of the National Cancer Institute|April 6, 2011
Induction of MET by ionizing radiation and its role in radioresistance and invasive growth of cancerFrancesca De Bacco, Paolo Luraghi, Enzo Medico, et al.Pageof 5